SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-036395
Filing Date
2024-03-26
Accepted
2024-03-26 16:01:11
Documents
12
Period of Report
2024-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bcab-20240326.htm   iXBRL 8-K 39790
2 EX-99.1 bcab-ex99_1.htm EX-99.1 137700
  Complete submission text file 0000950170-24-036395.txt   302073

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bcab-20240326.xsd EX-101.SCH 23882
16 EXTRACTED XBRL INSTANCE DOCUMENT bcab-20240326_htm.xml XML 4516
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39787 | Film No.: 24783428
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)